Pemetrexed disodium

• Target :

  DNA/RNA Synthesis|||Autophagy|||DHFR|||Apoptosis|||Antifolate

• Related Pathways :

  Apoptosis|||Metabolism|||Autophagy|||Cell Cycle/Checkpoint|||DNA Damage/DNA Repair

• Purity :

  0.9992

• Bioactivity :

  Pemetrexed disodium (LY-231514) is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of non-small cell lung cancer and malignant mesothelioma. Pemetrexed disodium therapy has been associated with moderate rates of serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury.

• Smiles :

  [Na+].[Na+].Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)c2c(=O)[nH]1

• Molecular Formula :

  C20H19N5Na2O6

• Molecular Weight :

  471.37

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  150399-23-8